DUBLIN, Feb. 20, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will present at the TD Cowen 45 th Annual Health Care Conference on Tuesday, March 4 at 11:50 am EST (8:50 am PST/4: ...

Oppenheimer downgraded Sutro Biopharma (STRO) to Perform from Outperform. Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses.

BofA analyst Tazeen Ahmad downgraded Sutro Biopharma (STRO) to Underperform from Buy with a price target of $1, down from $11. Published first on TheFly – the ultimate source for real-time ...

DUBLIN, Feb. 20, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will present at the TD Cowen 45 th Annual Health Care Conference on Tuesday, March 4 at 11:50 am EST (8:50 am PST/4:50 ...

Swedish Orphan Biovitrum (Sobi) has agreed a $1.7 billion merger deal to acquire CTI BioPharma and its recently-approved Vonjo drug for people with blood cancer myelofibrosis and severe ...

Aspire Biopharma Holdings, Inc. ("Aspire Biopharma") is scheduled to begin trading on Nasdaq on February 20, 2025 under the ticker symbol "ASBP". HUMACO, PR AND NEW YORK, NY / ACCESS Newswire ...

This brings an inflection point in the biopharma sector, by forging a sustainable pathway for the industry to cater to India’s collective aim of a 45% reduction in emission intensity by 2030 and ...

GC Biopharma announced on the 14th that it received approval from the Ministry of Food and Drug Safety for the clinical trial plan (IND) for an adult combined vaccine against tetanus, diphtheria ...

With the rising global obesity epidemic and the increasing demand for effective weight-loss treatments, the biopharma industry faces mounting pressure to revolutionize GLP-1 manufacturing to meet ...

Lead asset CR-001, a tetravalent PD-1 x VEGF bispecific antibody, on track for IND filing in the fourth quarter of 2025 Novel ADCs CR-002 and CR-003 on track for development as single agents and ...

SAN FRANCISCO - GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company with a market capitalization of $4.63 million, has announced the withdrawal of its Registration ...